nodes	percent_of_prediction	percent_of_DWPC	metapath
Etomidate—CYP19A1—Betamethasone—multiple sclerosis	0.334	0.632	CbGbCtD
Etomidate—CYP19A1—Dexamethasone—multiple sclerosis	0.194	0.368	CbGbCtD
Etomidate—SLC2A1—brainstem—multiple sclerosis	0.0133	0.0935	CbGeAlD
Etomidate—SLC2A1—retina—multiple sclerosis	0.0128	0.0902	CbGeAlD
Etomidate—SLC2A1—midbrain—multiple sclerosis	0.00845	0.0596	CbGeAlD
Etomidate—SLC2A1—spinal cord—multiple sclerosis	0.00825	0.0581	CbGeAlD
Etomidate—Pseudoephedrine—IL2—multiple sclerosis	0.00722	0.467	CrCbGaD
Etomidate—SLC2A1—nervous system—multiple sclerosis	0.00695	0.049	CbGeAlD
Etomidate—SLC2A1—central nervous system—multiple sclerosis	0.00669	0.0472	CbGeAlD
Etomidate—SLC2A1—cerebellum—multiple sclerosis	0.00654	0.0461	CbGeAlD
Etomidate—SLC2A1—brain—multiple sclerosis	0.00531	0.0374	CbGeAlD
Etomidate—GABRB2—brainstem—multiple sclerosis	0.00517	0.0365	CbGeAlD
Etomidate—GABRA1—brainstem—multiple sclerosis	0.00457	0.0322	CbGeAlD
Etomidate—GABRB2—medulla oblongata—multiple sclerosis	0.00361	0.0254	CbGeAlD
Etomidate—GABRG2—medulla oblongata—multiple sclerosis	0.00361	0.0254	CbGeAlD
Etomidate—Ephedrine—BCHE—multiple sclerosis	0.00331	0.214	CrCbGaD
Etomidate—GABRB2—midbrain—multiple sclerosis	0.0033	0.0232	CbGeAlD
Etomidate—GABRG2—midbrain—multiple sclerosis	0.0033	0.0232	CbGeAlD
Etomidate—GABRG2—spinal cord—multiple sclerosis	0.00322	0.0227	CbGeAlD
Etomidate—GABRB2—spinal cord—multiple sclerosis	0.00322	0.0227	CbGeAlD
Etomidate—GABRA1—medulla oblongata—multiple sclerosis	0.00318	0.0225	CbGeAlD
Etomidate—GABRA1—midbrain—multiple sclerosis	0.00291	0.0205	CbGeAlD
Etomidate—GABRA1—spinal cord—multiple sclerosis	0.00284	0.02	CbGeAlD
Etomidate—GABRB2—nervous system—multiple sclerosis	0.00271	0.0191	CbGeAlD
Etomidate—GABRG2—nervous system—multiple sclerosis	0.00271	0.0191	CbGeAlD
Etomidate—GABRB2—central nervous system—multiple sclerosis	0.00261	0.0184	CbGeAlD
Etomidate—GABRG2—central nervous system—multiple sclerosis	0.00261	0.0184	CbGeAlD
Etomidate—GABRB2—cerebellum—multiple sclerosis	0.00255	0.018	CbGeAlD
Etomidate—GABRG2—cerebellum—multiple sclerosis	0.00255	0.018	CbGeAlD
Etomidate—Pseudoephedrine—TNF—multiple sclerosis	0.00244	0.158	CrCbGaD
Etomidate—GABRA1—nervous system—multiple sclerosis	0.00239	0.0169	CbGeAlD
Etomidate—GABRA1—central nervous system—multiple sclerosis	0.0023	0.0162	CbGeAlD
Etomidate—GABRA1—cerebellum—multiple sclerosis	0.00225	0.0159	CbGeAlD
Etomidate—CYP19A1—nervous system—multiple sclerosis	0.0022	0.0155	CbGeAlD
Etomidate—CYP19A1—central nervous system—multiple sclerosis	0.00211	0.0149	CbGeAlD
Etomidate—GABRB2—brain—multiple sclerosis	0.00207	0.0146	CbGeAlD
Etomidate—GABRG2—brain—multiple sclerosis	0.00207	0.0146	CbGeAlD
Etomidate—GABRA1—brain—multiple sclerosis	0.00183	0.0129	CbGeAlD
Etomidate—CYP19A1—brain—multiple sclerosis	0.00168	0.0118	CbGeAlD
Etomidate—Fenoprofen—ALB—multiple sclerosis	0.00142	0.0916	CrCbGaD
Etomidate—Pethidine—ALB—multiple sclerosis	0.00107	0.0691	CrCbGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000882	0.00293	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000882	0.00293	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP24A1—multiple sclerosis	0.000871	0.0029	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—CYP27B1—multiple sclerosis	0.000871	0.0029	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—S1PR1—multiple sclerosis	0.000861	0.00286	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000856	0.00285	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—POMC—multiple sclerosis	0.000852	0.00283	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—GPC5—multiple sclerosis	0.000797	0.00265	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.000784	0.00261	CbGpPWpGaD
Etomidate—SLC2A1—NRF2 pathway—TGFB1—multiple sclerosis	0.000754	0.00251	CbGpPWpGaD
Etomidate—SLC2A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000751	0.0025	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000732	0.00243	CbGpPWpGaD
Etomidate—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000728	0.00242	CbGpPWpGaD
Etomidate—SLC2A1—Insulin Signaling—MAPK1—multiple sclerosis	0.000687	0.00228	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000684	0.00227	CbGpPWpGaD
Etomidate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00068	0.00226	CbGpPWpGaD
Etomidate—Bradycardia—Fingolimod—multiple sclerosis	0.000676	0.0489	CcSEcCtD
Etomidate—SLC2A1—Metabolism—RRM1—multiple sclerosis	0.00066	0.0022	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—CD58—multiple sclerosis	0.000654	0.00217	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MERTK—multiple sclerosis	0.000654	0.00217	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SELPLG—multiple sclerosis	0.000654	0.00217	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—SRM—multiple sclerosis	0.000647	0.00215	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000644	0.00214	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000634	0.00211	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000634	0.00211	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—IL2—multiple sclerosis	0.00063	0.00209	CbGpPWpGaD
Etomidate—SLC2A1—Disease—RPL5—multiple sclerosis	0.000619	0.00206	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000604	0.00201	CbGpPWpGaD
Etomidate—CYP11B2—Biological oxidations—POMC—multiple sclerosis	0.000599	0.00199	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000593	0.00197	CbGpPWpGaD
Etomidate—SLC2A1—Disease—SLC11A1—multiple sclerosis	0.000593	0.00197	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000589	0.00196	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—SRM—multiple sclerosis	0.000557	0.00185	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000552	0.00184	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000552	0.00183	CbGpPWpGaD
Etomidate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000551	0.00183	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000542	0.0018	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—S1PR1—multiple sclerosis	0.000521	0.00173	CbGpPWpGaD
Etomidate—CYP11B1—Biological oxidations—POMC—multiple sclerosis	0.000517	0.00172	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.000504	0.00168	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.000504	0.00168	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.0005	0.00166	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.0005	0.00166	CbGpPWpGaD
Etomidate—Hypertension—Fingolimod—multiple sclerosis	0.000499	0.0361	CcSEcCtD
Etomidate—CYP11B1—Corticotropin-releasing hormone—TGFB1—multiple sclerosis	0.000491	0.00163	CbGpPWpGaD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000483	0.0016	CbGpPWpGaD
Etomidate—CYP11B1—Corticotropin-releasing hormone—MAPK1—multiple sclerosis	0.000482	0.0016	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000474	0.00158	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD28—multiple sclerosis	0.000473	0.00157	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000458	0.00152	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP27B1—multiple sclerosis	0.000456	0.00152	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—CYP24A1—multiple sclerosis	0.000456	0.00152	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—BCHE—multiple sclerosis	0.000454	0.00151	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000445	0.00148	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000443	0.00147	CbGpPWpGaD
Etomidate—Hypotension—Fingolimod—multiple sclerosis	0.000441	0.0319	CcSEcCtD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000423	0.00141	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.00042	0.0014	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—GPR65—multiple sclerosis	0.00042	0.0014	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000418	0.00139	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—GPC5—multiple sclerosis	0.000417	0.00139	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—BCHE—multiple sclerosis	0.000416	0.00138	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000409	0.00136	CbGpPWpGaD
Etomidate—Hiccups—Prednisolone—multiple sclerosis	0.000404	0.0293	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—PLEK—multiple sclerosis	0.000404	0.00134	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000404	0.00134	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP24A1—multiple sclerosis	0.000393	0.00131	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—CYP27B1—multiple sclerosis	0.000393	0.00131	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.00039	0.0013	CbGpPWpGaD
Etomidate—Hypoxia—Methotrexate—multiple sclerosis	0.000386	0.028	CcSEcCtD
Etomidate—ADRA2B—GPCR ligand binding—CXCL13—multiple sclerosis	0.000384	0.00128	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCR1—multiple sclerosis	0.000384	0.00128	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000384	0.00128	CbGpPWpGaD
Etomidate—SLC2A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000382	0.00127	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000379	0.00126	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—BCHE—multiple sclerosis	0.000379	0.00126	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000377	0.00125	CbGpPWpGaD
Etomidate—Hiccups—Triamcinolone—multiple sclerosis	0.000372	0.0269	CcSEcCtD
Etomidate—Hiccups—Methylprednisolone—multiple sclerosis	0.000371	0.0269	CcSEcCtD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000366	0.00122	CbGpPWpGaD
Etomidate—GABRA1—Neuronal System—BCHE—multiple sclerosis	0.000363	0.00121	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000362	0.0012	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.000359	0.00119	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—GPC5—multiple sclerosis	0.000359	0.00119	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	0.00035	0.00116	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.000346	0.00115	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—RRM1—multiple sclerosis	0.000345	0.00115	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CXCL10—multiple sclerosis	0.00034	0.00113	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD86—multiple sclerosis	0.000338	0.00112	CbGpPWpGaD
Etomidate—Hiccups—Betamethasone—multiple sclerosis	0.000337	0.0244	CcSEcCtD
Etomidate—Hiccups—Dexamethasone—multiple sclerosis	0.000337	0.0244	CcSEcCtD
Etomidate—Arrhythmia—Cladribine—multiple sclerosis	0.000336	0.0243	CcSEcCtD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.000334	0.00111	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000331	0.0011	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.000325	0.00108	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.00032	0.00106	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—SRM—multiple sclerosis	0.000316	0.00105	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.0003	0.000997	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CCR5—multiple sclerosis	0.000299	0.000996	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—RRM1—multiple sclerosis	0.000298	0.000989	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—S1PR1—multiple sclerosis	0.000294	0.000979	CbGpPWpGaD
Etomidate—Hiccups—Prednisone—multiple sclerosis	0.000294	0.0213	CcSEcCtD
Etomidate—CYP19A1—Biological oxidations—POMC—multiple sclerosis	0.000293	0.000973	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000292	0.000972	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCL5—multiple sclerosis	0.000292	0.000972	CbGpPWpGaD
Etomidate—SLC2A1—Disease—HLA-A—multiple sclerosis	0.000292	0.00097	CbGpPWpGaD
Etomidate—Apnoea—Methotrexate—multiple sclerosis	0.00029	0.021	CcSEcCtD
Etomidate—GABRA1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000289	0.000961	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—SELE—multiple sclerosis	0.000285	0.000946	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL3—multiple sclerosis	0.000274	0.00091	CbGpPWpGaD
Etomidate—Arrhythmia—Azathioprine—multiple sclerosis	0.000273	0.0198	CcSEcCtD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.000273	0.000907	CbGpPWpGaD
Etomidate—SLC2A1—Disease—APOE—multiple sclerosis	0.000272	0.000906	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00027	0.000898	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000268	0.000891	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—S1PR1—multiple sclerosis	0.000267	0.000889	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—PTGER4—multiple sclerosis	0.000263	0.000876	CbGpPWpGaD
Etomidate—ADRA2B—G alpha (i) signalling events—CCR5—multiple sclerosis	0.000263	0.000876	CbGpPWpGaD
Etomidate—Tachycardia—Cladribine—multiple sclerosis	0.000261	0.0189	CcSEcCtD
Etomidate—GABRA1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000256	0.00085	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCR3—multiple sclerosis	0.000254	0.000846	CbGpPWpGaD
Etomidate—Bradycardia—Mitoxantrone—multiple sclerosis	0.000252	0.0182	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—RGS1—multiple sclerosis	0.00025	0.000832	CbGpPWpGaD
Etomidate—Respiratory failure—Methotrexate—multiple sclerosis	0.00025	0.0181	CcSEcCtD
Etomidate—Hypotension—Cladribine—multiple sclerosis	0.00025	0.0181	CcSEcCtD
Etomidate—ADRA2B—GPCR ligand binding—CCR2—multiple sclerosis	0.000248	0.000823	CbGpPWpGaD
Etomidate—SLC2A1—Disease—CD80—multiple sclerosis	0.000246	0.000819	CbGpPWpGaD
Etomidate—ADRA2B—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000244	0.000813	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—GPR65—multiple sclerosis	0.000237	0.000789	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000232	0.000773	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000231	0.000768	CbGpPWpGaD
Etomidate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000231	0.000767	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.00023	0.000765	CbGpPWpGaD
Etomidate—Pain—Cladribine—multiple sclerosis	0.000229	0.0166	CcSEcCtD
Etomidate—ADRA2B—GPCR ligand binding—CNR1—multiple sclerosis	0.000228	0.000759	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—APOE—multiple sclerosis	0.000228	0.000759	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—RGS1—multiple sclerosis	0.000227	0.000756	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	0.000223	0.00074	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	0.000223	0.00074	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000222	0.000737	CbGpPWpGaD
Etomidate—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000221	0.016	CcSEcCtD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000218	0.000723	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR1—multiple sclerosis	0.000217	0.000722	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000217	0.000722	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—GPR65—multiple sclerosis	0.000216	0.000717	CbGpPWpGaD
Etomidate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000211	0.000701	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.00021	0.000698	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000209	0.000696	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—LINGO1—multiple sclerosis	0.000208	0.000693	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TYK2—multiple sclerosis	0.000208	0.000691	CbGpPWpGaD
Etomidate—Bradycardia—Prednisolone—multiple sclerosis	0.000207	0.015	CcSEcCtD
Etomidate—ADRA2B—G alpha (i) signalling events—POMC—multiple sclerosis	0.000206	0.000685	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ITGA4—multiple sclerosis	0.000206	0.000684	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CXCL10—multiple sclerosis	0.000206	0.000684	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IFNB1—multiple sclerosis	0.000204	0.000679	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—GPC5—multiple sclerosis	0.000204	0.000677	CbGpPWpGaD
Etomidate—Hypotension—Azathioprine—multiple sclerosis	0.000203	0.0147	CcSEcCtD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000198	0.000659	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—BCHE—multiple sclerosis	0.000198	0.000659	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.000197	0.000655	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR1—multiple sclerosis	0.000197	0.000655	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL13—multiple sclerosis	0.000197	0.000655	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—POMC—multiple sclerosis	0.000196	0.000652	CbGpPWpGaD
Etomidate—Bradycardia—Triamcinolone—multiple sclerosis	0.00019	0.0138	CcSEcCtD
Etomidate—Bradycardia—Methylprednisolone—multiple sclerosis	0.00019	0.0137	CcSEcCtD
Etomidate—SLC2A1—Disease—CD4—multiple sclerosis	0.000188	0.000625	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	0.000188	0.000624	CbGpPWpGaD
Etomidate—Convulsion—Mitoxantrone—multiple sclerosis	0.000187	0.0135	CcSEcCtD
Etomidate—Hypertension—Mitoxantrone—multiple sclerosis	0.000186	0.0135	CcSEcCtD
Etomidate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000184	0.000613	CbGpPWpGaD
Etomidate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	0.000184	0.000611	CbGpPWpGaD
Etomidate—Arrhythmia—Prednisolone—multiple sclerosis	0.000181	0.0131	CcSEcCtD
Etomidate—CYP11B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000181	0.000601	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TAGAP—multiple sclerosis	0.000181	0.000601	CbGpPWpGaD
Etomidate—SLC2A1—Metabolism—ALB—multiple sclerosis	0.000179	0.000594	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL5—multiple sclerosis	0.000177	0.000589	CbGpPWpGaD
Etomidate—GABRB2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000173	0.000576	CbGpPWpGaD
Etomidate—Bradycardia—Betamethasone—multiple sclerosis	0.000172	0.0125	CcSEcCtD
Etomidate—Bradycardia—Dexamethasone—multiple sclerosis	0.000172	0.0125	CcSEcCtD
Etomidate—Tachycardia—Mitoxantrone—multiple sclerosis	0.000172	0.0124	CcSEcCtD
Etomidate—CYP11B1—Metabolism—BCHE—multiple sclerosis	0.000171	0.000568	CbGpPWpGaD
Etomidate—Vomiting—Cladribine—multiple sclerosis	0.00017	0.0123	CcSEcCtD
Etomidate—CYP19A1—Metabolism—RRM1—multiple sclerosis	0.000169	0.000561	CbGpPWpGaD
Etomidate—Arrhythmia—Triamcinolone—multiple sclerosis	0.000167	0.0121	CcSEcCtD
Etomidate—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000166	0.012	CcSEcCtD
Etomidate—Hypotension—Mitoxantrone—multiple sclerosis	0.000164	0.0119	CcSEcCtD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000164	0.000544	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000161	0.000535	CbGpPWpGaD
Etomidate—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00016	0.000533	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.00016	0.000532	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCR5—multiple sclerosis	0.00016	0.00053	CbGpPWpGaD
Etomidate—GABRG2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000159	0.000527	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—S1PR1—multiple sclerosis	0.000158	0.000525	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—GPC5—multiple sclerosis	0.000154	0.000511	CbGpPWpGaD
Etomidate—Convulsion—Prednisolone—multiple sclerosis	0.000153	0.0111	CcSEcCtD
Etomidate—Hypertension—Prednisolone—multiple sclerosis	0.000153	0.011	CcSEcCtD
Etomidate—Arrhythmia—Dexamethasone—multiple sclerosis	0.000151	0.011	CcSEcCtD
Etomidate—Arrhythmia—Betamethasone—multiple sclerosis	0.000151	0.011	CcSEcCtD
Etomidate—Pain—Mitoxantrone—multiple sclerosis	0.00015	0.0109	CcSEcCtD
Etomidate—Bradycardia—Prednisone—multiple sclerosis	0.00015	0.0109	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000149	0.000495	CbGpPWpGaD
Etomidate—SLC2A1—Disease—STAT3—multiple sclerosis	0.000146	0.000484	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000144	0.000478	CbGpPWpGaD
Etomidate—Convulsion—Triamcinolone—multiple sclerosis	0.000141	0.0102	CcSEcCtD
Etomidate—Tachycardia—Prednisolone—multiple sclerosis	0.000141	0.0102	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—IL2RA—multiple sclerosis	0.000141	0.000467	CbGpPWpGaD
Etomidate—Convulsion—Methylprednisolone—multiple sclerosis	0.00014	0.0102	CcSEcCtD
Etomidate—ADRA2B—Signaling by GPCR—CCL3—multiple sclerosis	0.00014	0.000467	CbGpPWpGaD
Etomidate—Hypertension—Triamcinolone—multiple sclerosis	0.00014	0.0102	CcSEcCtD
Etomidate—Hypertension—Methylprednisolone—multiple sclerosis	0.00014	0.0101	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—CCR2—multiple sclerosis	0.00014	0.000465	CbGpPWpGaD
Etomidate—GABRA1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000139	0.000461	CbGpPWpGaD
Etomidate—Vomiting—Azathioprine—multiple sclerosis	0.000138	0.01	CcSEcCtD
Etomidate—SLC2A1—Disease—MYC—multiple sclerosis	0.000135	0.00045	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—PTGER4—multiple sclerosis	0.000135	0.00045	CbGpPWpGaD
Etomidate—SLC2A1—Disease—TGFB1—multiple sclerosis	0.000135	0.000449	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—RGS1—multiple sclerosis	0.000134	0.000447	CbGpPWpGaD
Etomidate—GABRB2—Neuronal System—MAPK1—multiple sclerosis	0.000133	0.000442	CbGpPWpGaD
Etomidate—SLC2A1—Disease—MAPK1—multiple sclerosis	0.000132	0.00044	CbGpPWpGaD
Etomidate—Arrhythmia—Prednisone—multiple sclerosis	0.000132	0.00954	CcSEcCtD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000131	0.000435	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCR3—multiple sclerosis	0.000131	0.000434	CbGpPWpGaD
Etomidate—GABRA1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.00013	0.000432	CbGpPWpGaD
Etomidate—Tachycardia—Triamcinolone—multiple sclerosis	0.000129	0.00937	CcSEcCtD
Etomidate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000129	0.00935	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—CNR1—multiple sclerosis	0.000129	0.000429	CbGpPWpGaD
Etomidate—Convulsion—Dexamethasone—multiple sclerosis	0.000128	0.00925	CcSEcCtD
Etomidate—Convulsion—Betamethasone—multiple sclerosis	0.000128	0.00925	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—GPR65—multiple sclerosis	0.000127	0.000423	CbGpPWpGaD
Etomidate—Hypertension—Betamethasone—multiple sclerosis	0.000127	0.00922	CcSEcCtD
Etomidate—Hypertension—Dexamethasone—multiple sclerosis	0.000127	0.00922	CcSEcCtD
Etomidate—ADRA2B—Signaling by GPCR—CCR2—multiple sclerosis	0.000127	0.000422	CbGpPWpGaD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.000125	0.000415	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—POMC—multiple sclerosis	0.000125	0.000414	CbGpPWpGaD
Etomidate—Hypotension—Methylprednisolone—multiple sclerosis	0.000124	0.00895	CcSEcCtD
Etomidate—Pain—Prednisolone—multiple sclerosis	0.000123	0.00893	CcSEcCtD
Etomidate—ADRA2B—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.000122	0.000407	CbGpPWpGaD
Etomidate—ADRA2B—GPCR ligand binding—CCL2—multiple sclerosis	0.000122	0.000406	CbGpPWpGaD
Etomidate—GABRG2—Neuronal System—MAPK1—multiple sclerosis	0.000121	0.000404	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—APOE—multiple sclerosis	0.000119	0.000397	CbGpPWpGaD
Etomidate—Tachycardia—Dexamethasone—multiple sclerosis	0.000117	0.0085	CcSEcCtD
Etomidate—Tachycardia—Betamethasone—multiple sclerosis	0.000117	0.0085	CcSEcCtD
Etomidate—ADRA2B—Signaling by GPCR—CNR1—multiple sclerosis	0.000117	0.00039	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR1—multiple sclerosis	0.000116	0.000387	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL13—multiple sclerosis	0.000116	0.000387	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000116	0.000386	CbGpPWpGaD
Etomidate—GABRB2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000115	0.000383	CbGpPWpGaD
Etomidate—Pain—Triamcinolone—multiple sclerosis	0.000113	0.00821	CcSEcCtD
Etomidate—Hypotension—Betamethasone—multiple sclerosis	0.000112	0.00814	CcSEcCtD
Etomidate—Hypotension—Dexamethasone—multiple sclerosis	0.000112	0.00814	CcSEcCtD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000112	0.000374	CbGpPWpGaD
Etomidate—Vomiting—Mitoxantrone—multiple sclerosis	0.000112	0.00809	CcSEcCtD
Etomidate—Convulsion—Prednisone—multiple sclerosis	0.000111	0.00805	CcSEcCtD
Etomidate—Hypertension—Prednisone—multiple sclerosis	0.000111	0.00803	CcSEcCtD
Etomidate—GABRA1—Neuronal System—MAPK1—multiple sclerosis	0.000106	0.000353	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CXCL10—multiple sclerosis	0.000106	0.000351	CbGpPWpGaD
Etomidate—GABRG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000105	0.00035	CbGpPWpGaD
Etomidate—Pain—Betamethasone—multiple sclerosis	0.000103	0.00745	CcSEcCtD
Etomidate—Pain—Dexamethasone—multiple sclerosis	0.000103	0.00745	CcSEcCtD
Etomidate—CYP11B1—Metabolism—APOE—multiple sclerosis	0.000103	0.000342	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—POMC—multiple sclerosis	0.000103	0.000341	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000102	0.000341	CbGpPWpGaD
Etomidate—Tachycardia—Prednisone—multiple sclerosis	0.000102	0.00741	CcSEcCtD
Etomidate—SLC2A1—Disease—IL6—multiple sclerosis	0.000102	0.000338	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—ALB—multiple sclerosis	0.000102	0.000338	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCL5—multiple sclerosis	0.0001	0.000333	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—BCHE—multiple sclerosis	9.69e-05	0.000322	CbGpPWpGaD
Etomidate—CYP11B2—Metabolism—ALB—multiple sclerosis	9.35e-05	0.000311	CbGpPWpGaD
Etomidate—Convulsion—Methotrexate—multiple sclerosis	9.3e-05	0.00673	CcSEcCtD
Etomidate—GABRA1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.2e-05	0.000306	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL5—multiple sclerosis	9.09e-05	0.000302	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—CCR5—multiple sclerosis	9.01e-05	0.0003	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	8.88e-05	0.000295	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—POMC—multiple sclerosis	8.83e-05	0.000294	CbGpPWpGaD
Etomidate—Vomiting—Triamcinolone—multiple sclerosis	8.43e-05	0.00611	CcSEcCtD
Etomidate—Vomiting—Methylprednisolone—multiple sclerosis	8.41e-05	0.00609	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—CCL3—multiple sclerosis	8.3e-05	0.000276	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—IL2—multiple sclerosis	8.24e-05	0.000274	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCR5—multiple sclerosis	8.19e-05	0.000272	CbGpPWpGaD
Etomidate—Hypotension—Methotrexate—multiple sclerosis	8.18e-05	0.00593	CcSEcCtD
Etomidate—ADRA2B—Signaling by GPCR—IL2RA—multiple sclerosis	8.07e-05	0.000268	CbGpPWpGaD
Etomidate—CYP11B1—Metabolism—ALB—multiple sclerosis	8.05e-05	0.000268	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PTGER4—multiple sclerosis	7.99e-05	0.000266	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—PGR—multiple sclerosis	7.87e-05	0.000262	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCR3—multiple sclerosis	7.71e-05	0.000256	CbGpPWpGaD
Etomidate—Vomiting—Dexamethasone—multiple sclerosis	7.65e-05	0.00554	CcSEcCtD
Etomidate—Vomiting—Betamethasone—multiple sclerosis	7.65e-05	0.00554	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—CD28—multiple sclerosis	7.64e-05	0.000254	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR2—multiple sclerosis	7.5e-05	0.000249	CbGpPWpGaD
Etomidate—Pain—Methotrexate—multiple sclerosis	7.49e-05	0.00542	CcSEcCtD
Etomidate—ADRA2B—GPCR downstream signaling—POMC—multiple sclerosis	7.04e-05	0.000234	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CNR1—multiple sclerosis	6.92e-05	0.00023	CbGpPWpGaD
Etomidate—Vomiting—Prednisone—multiple sclerosis	6.66e-05	0.00482	CcSEcCtD
Etomidate—ADRA2B—Hemostasis—TGFB1—multiple sclerosis	6.43e-05	0.000214	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—POMC—multiple sclerosis	6.4e-05	0.000213	CbGpPWpGaD
Etomidate—ADRA2B—Hemostasis—MAPK1—multiple sclerosis	6.3e-05	0.00021	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—CCL2—multiple sclerosis	6.26e-05	0.000208	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CXCL10—multiple sclerosis	6.24e-05	0.000207	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—APOE—multiple sclerosis	5.83e-05	0.000194	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—TYK2—multiple sclerosis	5.68e-05	0.000189	CbGpPWpGaD
Etomidate—Vomiting—Methotrexate—multiple sclerosis	5.57e-05	0.00403	CcSEcCtD
Etomidate—ADRA2B—Signaling Pathways—CD86—multiple sclerosis	5.45e-05	0.000181	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL5—multiple sclerosis	5.37e-05	0.000178	CbGpPWpGaD
Etomidate—ADRA2B—GPCR downstream signaling—IL2—multiple sclerosis	5.21e-05	0.000173	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—POMC—multiple sclerosis	5.01e-05	0.000166	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—SPP1—multiple sclerosis	4.97e-05	0.000165	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCR5—multiple sclerosis	4.84e-05	0.000161	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2RA—multiple sclerosis	4.77e-05	0.000158	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL2—multiple sclerosis	4.73e-05	0.000157	CbGpPWpGaD
Etomidate—CYP19A1—Metabolism—ALB—multiple sclerosis	4.56e-05	0.000152	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—APOE—multiple sclerosis	4.4e-05	0.000146	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CD80—multiple sclerosis	3.98e-05	0.000132	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—POMC—multiple sclerosis	3.78e-05	0.000126	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—CCL2—multiple sclerosis	3.7e-05	0.000123	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—MAPK1—multiple sclerosis	3.62e-05	0.00012	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TYK2—multiple sclerosis	3.36e-05	0.000112	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL2—multiple sclerosis	2.79e-05	9.29e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling by GPCR—IL6—multiple sclerosis	2.78e-05	9.24e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MMP9—multiple sclerosis	2.64e-05	8.79e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—STAT3—multiple sclerosis	2.35e-05	7.82e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MYC—multiple sclerosis	2.18e-05	7.26e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—TGFB1—multiple sclerosis	2.18e-05	7.25e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—MAPK1—multiple sclerosis	2.14e-05	7.11e-05	CbGpPWpGaD
Etomidate—ADRA2B—Signaling Pathways—IL6—multiple sclerosis	1.64e-05	5.46e-05	CbGpPWpGaD
